Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality

Clinical Microbiology and Infection

Volumn 20, Issue 6, 2014, Pages 530-535

  Robinson, J O ^a,b   Phillips, M ^c   Christiansen, K J ^a,b   Pearson, J C ^a,b   Coombs, G W ^a,b   Murray, R J ^d,e  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Bacteraemia; Colonization; Methicillin resistant Staphylococcus aureus; Mortality; Staphylococcus aureus

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM; ADOLESCENT; AGED; CHILD; HETEROZYGOTE; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDY; STAPHYLOCOCCAL INFECTIONS; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CARRIER STATE; CHILD; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904417383     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12388     Document Type: Article

References (24)

1. Robinson JO, Pearson JC, Christiansen KJ, Coombs GW, Murray RJ. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2009; 28: 353-361.
2. Turnidge JD, Kotsanas D, Munckhof W et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191: 368-373.
3. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175: 264-267.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
5. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
6. Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010; 65: 2658-2665.
7. Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 2001; 48(suppl A): S9-S14.
8. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36: 281-285.
9. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
10. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
11. Schweizer ML, Furuno JP, Harris AD et al. Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy. Infect Control Hosp Epidemiol 2008; 29: 972-974.
12. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25: 181-185.
13. Rodriguez-Bano J, Millan AB, Dominguez MA et al. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect 2009; 58: 131-137.
14. Kim SH, Park WB, Lee KD et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004; 54: 489-497.
15. Fang CT, Shau WY, Hsueh PR et al. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother 2006; 57: 511-519.
16. Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus. Semin Immunopathol 2012; 34: 335-348.
17. Fowler VG, Allen KB, Moreira ED et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 2013; 309: 1368-1378.
18. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21: 1138-1145.
19. Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ. Patterns, trends, and increasing disparities in mortality for aboriginal and non-aboriginal infants born in Western Australia, 1980-2001: population database study. Lancet 2006; 367: 1758-1766.
20. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Committee tHICPA. Management of multidrug-resistant organisms in healthcare settings, 2006. Atlanta. 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf (last accessed 14 February 2013).
21. Assembly IG (210 ILCS 83/). MRSA screening and reporting act. Springfield, 2007. Available at: http://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=2919&ChapAct=210%A0ILCS%A083/&ChapterID=21&ChapterName=HEALTH%20FACILITIES&ActName=MRSA%20Screening%20and%20Reporting%20Act (last accessed 14 February 2013).
22. Harbarth S, Fankhauser C, Schrenzel J et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299: 1149-1157.
23. Robicsek A, Beaumont JL, Paule SM et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148: 409-418.
24. Jog S, Cunningham R, Cooper S et al. Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 2008; 69: 124-130.